BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/28/2025 3:10:34 AM | Browse: 285 | Download: 678
Publication Name World Journal of Gastroenterology
Manuscript ID 114404
Country Russia
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Letter to the Editor
Article Title Peroxiredoxin 1 inhibits tumorigenesis by activating the NLR family pyrin domain containing 3/gasdermin D pathway: Advanced therapies targeting heterogeneous cell death mechanisms
Manuscript Source Unsolicited Manuscript
All Author List Anna Smirnova, Daria Eygel, Irina Kondrasheva, Denis S Baranovskii and Ilya D Klabukov
ORCID
Author(s) ORCID Number
Anna Smirnova http://orcid.org/0000-0002-6485-3462
Irina Kondrasheva http://orcid.org/0009-0004-0060-4178
Denis S Baranovskii http://orcid.org/0000-0002-6154-9959
Ilya D Klabukov http://orcid.org/0000-0002-2888-7999
Funding Agency and Grant Number
Funding Agency Grant Number
Russian Science Foundation 24-64-00028
Corresponding Author Ilya D Klabukov, Director, PhD, Department of Regenerative Medicine, National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, No. 4 Koroleva Street, Obninsk 249036, Russia. ilya.klabukov@gmail.com
Key Words Cancer; Cell death; Colorectal cancer; Extracellular matrix; Mechanotransduction; mRNA therapy; Programmed cell death; Pyroptosis; Tumor microenvironment
Core Tip The molecular patterns of the special types of the programmed cell death, such as apoptosis, pyroptosis, ferroptosis and necroptosis, in cancer cells caused by the altered regulation, could improve the effectiveness of the mRNA vaccines and targeted therapies by overcoming the barrier function of the tumor microenvironment. Activation of specific pathways to overcome the barrier function in cancer treatment represents a promising strategy for targeted cellular and gene therapies, as well as for enhancing radiosensitivity in radiation therapy.
Publish Date 2025-11-28 03:10
Citation

Smirnova A, Eygel D, Kondrasheva I, Baranovskii DS, Klabukov ID. Peroxiredoxin 1 inhibits tumorigenesis by activating the NLR family pyrin domain containing 3/gasdermin D pathway: Advanced therapies targeting heterogeneous cell death mechanisms. World J Gastroenterol 2025; 31(44): 114404

URL https://www.wjgnet.com/1007-9327/full/v31/i44/114404.htm
DOI https://dx.doi.org/10.3748/wjg.v31.i44.114404
Full Article (PDF) WJG-31-114404-with-cover.pdf